来凯医药-B根据2024年股份奖励计划发行合计273万股普通股

Core Viewpoint - The company, 来凯医药-B (02105), announced the issuance of a total of 2.73 million ordinary shares on September 5, 2025, to fulfill the vesting of RSUs granted under the 2024 Share Incentive Plan [1] Summary by Relevant Categories - Share Issuance - The company will issue 2.73 million ordinary shares [1] - Incentive Plan - The share issuance is related to the vesting of RSUs under the 2024 Share Incentive Plan [1]